Chris Tame

Chief Executive Officer Ternary Therapeutics

Seminars

Thursday 29th January 2026
Accurate Prediction of Tractable Ternary Complexes & Optimised Molecular Glues for Any Protein-Protein Interaction
12:30 pm
  • An overview of Ternary’s end-to-end molecular glue design platform
  • Revealing in vitro validation of the platform
  • Exploring current limitations to AI-enabled molecular glue design
Chris